Tuning Nanoparticle Uptake: Live-Cell Imaging Reveals Two Distinct Endocytosis Mechanisms Mediated by Natural and Artificial EGFR Targeting Ligand-Reference-Cited by-同舟云学术

Tuning Nanoparticle Uptake: Live-Cell Imaging Reveals Two Distinct Endocytosis Mechanisms Mediated by Natural and Artificial EGFR Targeting Ligand

Published:2012-06-05 Issue:7 Volume:12 Page:3417-3423
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Mickler Frauke M.¹,Möckl Leonhard¹,Ruthardt Nadia¹,Ogris Manfred¹,Wagner Ernst¹,Bräuchle Christoph¹

Affiliation:

1. Department of Chemistry and Center for NanoScience (CeNS) and ‡Department of Pharmacy and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13, D-81377 München, Germany

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/nl300395q

Reference32 articles.

1. The dawning era of polymer therapeutics

2. Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer

3. Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting

4. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

5. Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines.

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocytosis: the match point of nanoparticle-based cancer therapy;Journal of Materials Chemistry B;2024

2. A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell Fusion;Advanced Science;2023-08-17

3. Enhancing the Management of Metastatic Tumors by Robust Co‐Delivery of 5‐Fluorouracil/MicroRNA‐10b Inhibitor Using EGFR‐Targeted Nanovehicles;Advanced Healthcare Materials;2023-02-21

4. Recent Advances in Boosting EGFR Tyrosine Kinase Inhibitors-Based Cancer Therapy;Molecular Pharmaceutics;2023-01-02

5. Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications;International Journal of Pharmaceutics: X;2022-12